Entrada Therapeutics, Inc. - TRDA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | — | P | A | 5,000.0 | 5.8632 | 29,316.0 | 5,000.0 | View | |
| May 04, 2026 | President, Research & Develop. | S | D | 25,907.0 | 15.3939 | 398,809.77 | 216,317.0 | View | |
| May 04, 2026 | President & COO | M | D | 15,000.0 | 0.0 | 0.0 | 49,831.0 | View | |
| May 04, 2026 | President & COO | S | D | 15,000.0 | 15.3302 | 229,953.0 | 198,588.0 | View | |
| May 04, 2026 | President & COO | M | A | 15,000.0 | 1.74 | 26,100.0 | 213,588.0 | View | |
| Apr 02, 2026 | Chief Financial Officer | S | D | 2,500.0 | 12.95 | 32,375.0 | 119,010.0 | View | |
| Mar 11, 2026 | President & COO | S | D | 11,894.0 | 13.0476 | 155,188.15 | 198,588.0 | View | |
| Mar 11, 2026 | President & COO | S | D | 3,116.0 | 13.024 | 40,582.78 | 210,482.0 | View | |
| Mar 11, 2026 | Chief Financial Officer | S | D | 11,388.0 | 13.0151 | 148,215.96 | 121,510.0 | View | |
| Mar 11, 2026 | Chief Financial Officer | S | D | 5,089.0 | 13.0011 | 66,162.6 | 132,898.0 | View | |
| Mar 06, 2026 | Chief Financial Officer | S | D | 7,988.0 | 12.2549 | 97,892.14 | 137,987.0 | View | |
| Mar 03, 2026 | President & COO | A | A | 83,200.0 | 0.0 | 0.0 | 83,200.0 | View | |
| Mar 03, 2026 | President & COO | F | D | 14,038.0 | 11.7564 | 165,036.34 | 213,598.0 | View | |
| Mar 03, 2026 | President & COO | F | D | 7,223.0 | 11.6579 | 84,205.01 | 227,636.0 | View | |
| Mar 03, 2026 | President & COO | A | A | 55,800.0 | 0.0 | 0.0 | 234,859.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | A | A | 66,600.0 | 0.0 | 0.0 | 66,600.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | F | D | 5,712.0 | 11.7564 | 67,152.56 | 145,975.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | F | D | 2,939.0 | 11.6579 | 34,262.57 | 151,687.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | A | A | 44,600.0 | 0.0 | 0.0 | 154,626.0 | View | |
| Mar 03, 2026 | CEO | A | A | 208,000.0 | 0.0 | 0.0 | 208,000.0 | View | |
| Mar 03, 2026 | CEO | F | D | 19,181.0 | 11.7564 | 225,499.51 | 526,014.0 | View | |
| Mar 03, 2026 | CEO | F | D | 9,869.0 | 11.6579 | 115,051.82 | 545,195.0 | View | |
| Mar 03, 2026 | CEO | A | A | 139,400.0 | 0.0 | 0.0 | 555,064.0 | View | |
| Mar 03, 2026 | President, Research & Develop. | A | A | 83,200.0 | 0.0 | 0.0 | 83,200.0 | View | |
| Mar 03, 2026 | President, Research & Develop. | F | D | 7,577.0 | 11.7564 | 89,078.24 | 242,224.0 | View | |
| Mar 03, 2026 | President, Research & Develop. | F | D | 3,898.0 | 11.6579 | 45,442.49 | 249,801.0 | View | |
| Mar 03, 2026 | President, Research & Develop. | A | A | 55,800.0 | 0.0 | 0.0 | 253,699.0 | View |